Randomized Prospective Open Label Study Shows No Impact on Clinical Outcome of Adding Losartan to Hospitalized COVID-19 Patients with Mild Hypoxemia
Geriak et al., Infectious Diseases and Therapy, doi:10.1007/s40121-021-00453-3
https://c19early.org/geriak.html